Top RX group vs CVP

Sophomore at a target and have an offer from a top rx group (EVR/HL/LAZ) and CVP for the summer analyst program. Interested in restructuring, but like the generalist platform CVP has for analysts. Which offer should I be leaning towards in your opinion?

7 Comments
 

if want to do buyout PE, u think the rx groups would be better than CVP?

 

HL (even NYC) buyout exits suck.

For Buyout PE: EVR RX > CVP > LAZ RX > HL RX

CVP will clawback your bonus if you try to leave after 2 years but the exits if you decide to leave are pretty great. Also, not a lot of people leave just due to the incredibly high pay. Honestly can’t go wrong with EVR or CVP but I’d honestly lean a little more towards CVP.

 
Most Helpful

I think it is pretty clear that the CVP generalist program is considered as elite as any group out there from a pure M&A perspective both in terms of prestige and experience. they absolutely killed it in 2023 and appear to be continuing that trend this year. Also, being a generalist will give you the opportunity to figure out what sector you are most interested in - having the opportunity to work in HC, consumer, industrials, FIG, etc. is pretty valuable imo. RX will give you great technical training but the work itself is slightly niche. Obviously those RX groups (specifically EVR and HL not sure about Lazard) place super well but Centerview's exits are misrepresented on this forum. You will 100% be able to get ANY PE interview you want as a Centerview analyst and at that point it just comes down to you as a candidate. the reason why you don't see as many traditional mega fund exits from Centerview is because 1. they have a way higher A2A retention rate than other firms 2. their analysts don't do on-cycle until after their 1st year and at that point a lot of kids are disenchanted with finance and realize they'd rather do something else. Also, worth noting that doing on-cycle after your first year will make you a way way more prepared candidate (much more polished, have deal experience, etc). Either way these are all great options. good luck with your decision. 

 

Aperiam at autem mollitia est nesciunt impedit. Quia temporibus repellendus temporibus animi molestias. Est qui eius voluptates pariatur.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (77) $151
  • Intern/Summer Analyst (72) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”